Home

About

• Corporate overview
• Business model
• Laboratory Services
• Board of Directors
• History

News

• Company news
• Regulatory news
• Email news alert

Investors

• Investors
• Corporate governance
• AIM Rule 26
• Share price
• Reports
• Events
• Major shareholders
• Advisors
• FAQs

Contacts

• Contact us
• Employment opportunities

Product pipeline

• Market opportunity
• Vaccines to attack cancer
• How It Works
• News
• Ruthenium chemotherapy
• How It Works
• News
• Ribozyme anti-virals
• How It Works
• News
• Technical glossary

 

Oncosense is a trading name of Medical Marketing International Group plc registered in England and Wales (No. 02990329)

Copyright 2009

Sitemap    |    Privacy Statement    |    Accessibility    |    Terms and Conditions    |    Print